Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07075107
NA

Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases

Sponsor: Assistance Publique Hopitaux De Marseille

View on ClinicalTrials.gov

Summary

This study aims to answer a key question in the field of rare genetic diseases by determining the prevalence of deleterious variants at RNA level in undiagnosed patients with intellectual disability and/or neonatal hypotonia. This study will put an end to diagnostic erraticism in a number of patients. Finally, the results of this study will make it possible to compare the two types of tissue used for RNAseq, with a view to facilitating the implementation of this analysis method in the diagnostic setting.

Official title: Transcriptomic Analysis (RNAseq) of Blood and Fibroblasts to Establish a Diagnosis in Patients With Rare Diseases

Key Details

Gender

All

Age Range

0 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

62

Start Date

2025-12-15

Completion Date

2029-04-30

Last Updated

2025-11-21

Healthy Volunteers

No

Interventions

PROCEDURE

Blood collection

Blood is collected in order to perform transcriptomic sequencing from blood

PROCEDURE

skin biopsy

A biopsy of skin is performed in order to perform transcriptomic sequencing on fibroblasts obtained from the biopsy

Locations (1)

Assistance publique - hôpitaux de Marseille

Marseille, Provence-Alpes-Côt-d'Azue, France